share_log

Earnings Report: Quaker Chemical Corporation Missed Revenue Estimates By 5.0%

Earnings Report: Quaker Chemical Corporation Missed Revenue Estimates By 5.0%

收益报告:贵格克化学公司未达到收入预期5.0%
Simply Wall St ·  05/06 15:20

Quaker Chemical Corporation (NYSE:KWR) shareholders are probably feeling a little disappointed, since its shares fell 2.5% to US$186 in the week after its latest first-quarter results.       Quaker Chemical missed revenue estimates by 5.0%, coming in atUS$470m, although statutory earnings per share (EPS) of US$1.96 beat expectations, coming in 4.5% ahead of analyst estimates.     This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business.  With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

贵格化学公司(纽约证券交易所代码:KWR)的股东可能会感到有些失望,因为其股价在公布最新的第一季度业绩后的一周内下跌了2.5%,至186美元。尽管法定每股收益(EPS)为1.96美元,超出预期,比分析师的预期高出4.5%,但贵格化学的收入未达到5.0%,为4.7亿美元。对于投资者来说,这是一个重要时刻,因为他们可以在报告中追踪公司的业绩,看看专家对明年的预测,看看对该业务的预期是否有任何变化。考虑到这一点,我们收集了最新的法定预测,以了解分析师对明年的预期。

NYSE:KWR Earnings and Revenue Growth May 6th 2024

纽约证券交易所:KWR 收益和收入增长 2024 年 5 月 6 日

Taking into account the latest results, the consensus forecast from Quaker Chemical's six analysts is for revenues of US$1.97b in 2024. This reflects a satisfactory 2.3% improvement in revenue compared to the last 12 months.       Statutory earnings per share are predicted to soar 31% to US$8.56.        Yet prior to the latest earnings, the analysts had been anticipated revenues of US$2.00b and earnings per share (EPS) of US$8.48 in 2024.        The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.    

考虑到最新业绩,贵格化学的六位分析师的共识预测是,2024年的收入为19.7亿美元。这反映出与过去12个月相比,收入增长了令人满意的2.3%。预计每股法定收益将飙升31%,至8.56美元。然而,在最新财报公布之前,分析师曾预计2024年的收入为20亿美元,每股收益(EPS)为8.48美元。鉴于他们的估计没有重大变化,共识分析师似乎没有在这些结果中看到任何会改变他们对业务看法的内容。

It will come as no surprise then, to learn that the consensus price target is largely unchanged at US$234.        There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business.   The most optimistic Quaker Chemical analyst has a price target of US$280 per share, while the most pessimistic values it at US$222.   The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.    

因此,得知共识目标股价基本保持不变为234美元也就不足为奇了。但是,还有另一种思考价格目标的方法,那就是研究分析师提出的价格目标范围,因为范围广泛的估计可能表明,对业务可能的结果有不同的看法。最乐观的贵格化学分析师将目标股价定为每股280美元,而最悲观的分析师则将其估值为222美元。估计值的狭窄差异可能表明该业务的未来相对容易估值,或者分析师对其前景有强烈的看法。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that Quaker Chemical's revenue growth is expected to slow, with the forecast 3.1% annualised growth rate until the end of 2024 being well below the historical 15% p.a. growth over the last five years.    Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 4.8% annually.  So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Quaker Chemical.    

我们可以从大局的角度看待这些估计值的另一种方式,例如预测如何与过去的表现相提并论,以及预测相对于业内其他公司是否或多或少看涨。我们要强调的是,贵格化学的收入增长预计将放缓,预计到2024年底的年化增长率为3.1%,远低于过去五年15%的历史年增长率。相比之下,该行业的其他公司(根据分析师的预测),后者的总体收入预计每年将增长4.8%。因此,很明显,尽管收入增长预计将放缓,但整个行业的增长速度预计也将超过贵格克化学。

The Bottom Line

底线

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates.        On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry.       The consensus price target held steady at US$234, with the latest estimates not enough to have an impact on their price targets.  

最明显的结论是,该业务的前景最近没有重大变化,分析师的收益预测保持稳定,与先前的估计一致。从好的方面来看,收入估计没有重大变化;尽管预测表明它们的表现将比整个行业差。共识目标股价稳定在234美元,最新估计不足以对其目标股价产生影响。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year.   We have forecasts for Quaker Chemical going out to 2026, and you can see them free on our platform here.

话虽如此,公司收益的长期轨迹比明年重要得多。我们对贵格化学的预测将持续到2026年,你可以在我们的平台上免费查看。

We don't want to rain on the parade too much, but we did also find 1 warning sign for Quaker Chemical that you need to be mindful of.  

我们不想在游行队伍中下太多雨,但我们也找到了贵格化学的一个警告标志,你需要注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发